These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2600796)

  • 21. Studies on hydralazine. III. Bioavailability of hydralazine in man.
    Talseth T
    Eur J Clin Pharmacol; 1976; 10(6):395-401. PubMed ID: 1001354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition of pentopril, a new orally active angiotensin-converting enzyme inhibitor, and its active metabolite in rats.
    Rakhit A; Kochak G; Dotson R; Tipnis V
    J Pharm Sci; 1985 Sep; 74(9):947-52. PubMed ID: 2999376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of hydralazine and its acid-labile hydrazone metabolites in relation to acetylator phenotype.
    Shen DD; Hosler JP; Schroder RL; Azarnoff DL
    J Pharmacokinet Biopharm; 1980 Feb; 8(1):53-68. PubMed ID: 7381691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of oral hydralazine in chronic heart failure.
    Hanson A; Johansson BW; Wernersson B; Wåhlander LA
    Eur J Clin Pharmacol; 1983; 25(4):467-73. PubMed ID: 6653641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydralazine pharmacokinetics and interaction with food: an evaluation of the dog as an animal model.
    Semple HA; Tam YK; Coutts RT
    Pharm Res; 1990 Mar; 7(3):274-9. PubMed ID: 2339102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-pressure liquid chromatographic assay for hydralazine in human plasma.
    Ludden TM; Goggin LK; McNay JL; Haegele KD; Shepherd AM
    J Pharm Sci; 1979 Nov; 68(11):1423-5. PubMed ID: 512893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the in vivo metabolism of hydralazine in the rat.
    Streeter AJ; Timbrell JA
    Drug Metab Dispos; 1983; 11(3):184-9. PubMed ID: 6135573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of in vitro effects of hydralazine metabolites--comparative evaluation of products of hydroxylation, hydrolysis and conjugation.
    McLean AJ; du Souich P; Barron K; Carrier O; Haegele KD; McNay JL
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):19-25. PubMed ID: 736689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of bendroflumethiazide alone and in combination with propranolol and hydralazine.
    Schäfer-Korting M; Mutschler E
    Eur J Clin Pharmacol; 1982; 21(4):315-23. PubMed ID: 7056277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetics and metabolic disposition of exogenous phosphocreatine in rats].
    Zou LL; Li QS; Han GZ; Lü L; Xi H; Li JH
    Yao Xue Xue Bao; 2011 Jan; 46(1):75-80. PubMed ID: 21465812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism and disposition of hydralazine-14C in man and dog.
    Lesser JM; Israili ZH; Davis DC; Dayton PG
    Drug Metab Dispos; 1974; 2(4):351-60. PubMed ID: 4153405
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolism of hydralazine in man. Part II: Investigation of features relevant to drug safety.
    Dubois JP; Schmid K; Riess W; Hanson A; Henningsen NC; Andersson OK
    Arzneimittelforschung; 1987 Feb; 37(2):189-93. PubMed ID: 3580022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis.
    Takeda S; Ishthara K; Wakui Y; Amagaya S; Maruno M; Akao T; Kobashi K
    J Pharm Pharmacol; 1996 Sep; 48(9):902-5. PubMed ID: 8910850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further evidence for an acetylator phenotype difference in the metabolism of hydralazine in man.
    Facchini V; Timbrell JA
    Br J Clin Pharmacol; 1981 Apr; 11(4):345-51. PubMed ID: 7259927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of hydralazine elimination.
    Talseth T
    Clin Pharmacol Ther; 1977 Jun; 21(6):715-20. PubMed ID: 862310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective high-performance liquid chromatographic assays for hydralazine and its metabolites in plasma of man.
    Reece PA; Cozamanis I; Zacest R
    J Chromatogr; 1980 Mar; 181(3-4):427-40. PubMed ID: 7391156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme-mediated covalent binding of hydralazine to rat liver microsomes.
    Streeter AJ; Timbrell JA
    Drug Metab Dispos; 1983; 11(3):179-83. PubMed ID: 6135572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotoxicity of the antihypertensive drugs hydralazine and dihydralazine.
    Williams GM; Mazue G; McQueen CA; Shimada T
    Science; 1980 Oct; 210(4467):329-30. PubMed ID: 7423193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in rats.
    Luo FR; Wyrick SD; Chaney SG
    Cancer Chemother Pharmacol; 1999; 44(1):19-28. PubMed ID: 10367745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of hydralazine and hydrazone derivatives with contractile mechanisms in rabbit aortic smooth muscle.
    McLean AJ; Barron K; du Souich P; Haegele KD; McNay JL; Carrier O; Briggs A
    J Pharmacol Exp Ther; 1978 May; 205(2):418-25. PubMed ID: 641837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.